nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Drowsiness—Mitomycin—stomach cancer	0.0165	0.0322	CcSEcCtD
Mepenzolate—Confusional state—Floxuridine—stomach cancer	0.0135	0.0264	CcSEcCtD
Mepenzolate—Anaphylactic shock—Floxuridine—stomach cancer	0.0134	0.0262	CcSEcCtD
Mepenzolate—Vision blurred—Mitomycin—stomach cancer	0.0121	0.0237	CcSEcCtD
Mepenzolate—Feeling abnormal—Floxuridine—stomach cancer	0.011	0.0216	CcSEcCtD
Mepenzolate—Ageusia—Docetaxel—stomach cancer	0.0109	0.0214	CcSEcCtD
Mepenzolate—Confusional state—Mitomycin—stomach cancer	0.0106	0.0207	CcSEcCtD
Mepenzolate—Ageusia—Capecitabine—stomach cancer	0.0106	0.0207	CcSEcCtD
Mepenzolate—Hypersensitivity—Floxuridine—stomach cancer	0.00987	0.0193	CcSEcCtD
Mepenzolate—Asthenia—Floxuridine—stomach cancer	0.00961	0.0188	CcSEcCtD
Mepenzolate—Somnolence—Mitomycin—stomach cancer	0.00935	0.0183	CcSEcCtD
Mepenzolate—Feeling abnormal—Mitomycin—stomach cancer	0.00867	0.0169	CcSEcCtD
Mepenzolate—Vomiting—Floxuridine—stomach cancer	0.00852	0.0167	CcSEcCtD
Mepenzolate—Headache—Floxuridine—stomach cancer	0.00839	0.0164	CcSEcCtD
Mepenzolate—Abdominal distension—Irinotecan—stomach cancer	0.00808	0.0158	CcSEcCtD
Mepenzolate—Nausea—Floxuridine—stomach cancer	0.00796	0.0156	CcSEcCtD
Mepenzolate—Asthenia—Mitomycin—stomach cancer	0.00754	0.0148	CcSEcCtD
Mepenzolate—Ageusia—Epirubicin—stomach cancer	0.00737	0.0144	CcSEcCtD
Mepenzolate—Dizziness—Mitomycin—stomach cancer	0.00695	0.0136	CcSEcCtD
Mepenzolate—Ageusia—Doxorubicin—stomach cancer	0.00682	0.0133	CcSEcCtD
Mepenzolate—Vomiting—Mitomycin—stomach cancer	0.00669	0.0131	CcSEcCtD
Mepenzolate—Headache—Mitomycin—stomach cancer	0.00659	0.0129	CcSEcCtD
Mepenzolate—Nausea—Mitomycin—stomach cancer	0.00625	0.0122	CcSEcCtD
Mepenzolate—Urinary retention—Capecitabine—stomach cancer	0.00591	0.0116	CcSEcCtD
Mepenzolate—Abdominal distension—Capecitabine—stomach cancer	0.00541	0.0106	CcSEcCtD
Mepenzolate—Vision blurred—Fluorouracil—stomach cancer	0.00505	0.00988	CcSEcCtD
Mepenzolate—Confusional state—Irinotecan—stomach cancer	0.0046	0.00901	CcSEcCtD
Mepenzolate—Anaphylactic shock—Irinotecan—stomach cancer	0.00457	0.00893	CcSEcCtD
Mepenzolate—Confusional state—Fluorouracil—stomach cancer	0.00441	0.00863	CcSEcCtD
Mepenzolate—Anaphylactic shock—Fluorouracil—stomach cancer	0.00437	0.00855	CcSEcCtD
Mepenzolate—Tachycardia—Fluorouracil—stomach cancer	0.00427	0.00835	CcSEcCtD
Mepenzolate—Insomnia—Irinotecan—stomach cancer	0.00413	0.00808	CcSEcCtD
Mepenzolate—Somnolence—Irinotecan—stomach cancer	0.00406	0.00794	CcSEcCtD
Mepenzolate—Insomnia—Fluorouracil—stomach cancer	0.00396	0.00774	CcSEcCtD
Mepenzolate—Constipation—Irinotecan—stomach cancer	0.00391	0.00764	CcSEcCtD
Mepenzolate—Somnolence—Fluorouracil—stomach cancer	0.00389	0.00761	CcSEcCtD
Mepenzolate—Abdominal distension—Epirubicin—stomach cancer	0.00377	0.00737	CcSEcCtD
Mepenzolate—Feeling abnormal—Irinotecan—stomach cancer	0.00376	0.00736	CcSEcCtD
Mepenzolate—Erectile dysfunction—Methotrexate—stomach cancer	0.00369	0.00721	CcSEcCtD
Mepenzolate—Feeling abnormal—Fluorouracil—stomach cancer	0.0036	0.00705	CcSEcCtD
Mepenzolate—Drowsiness—Methotrexate—stomach cancer	0.00357	0.00698	CcSEcCtD
Mepenzolate—Vision blurred—Capecitabine—stomach cancer	0.00353	0.0069	CcSEcCtD
Mepenzolate—Abdominal distension—Doxorubicin—stomach cancer	0.00349	0.00682	CcSEcCtD
Mepenzolate—Urticaria—Fluorouracil—stomach cancer	0.00347	0.0068	CcSEcCtD
Mepenzolate—Palpitations—Docetaxel—stomach cancer	0.00342	0.00669	CcSEcCtD
Mepenzolate—Hypersensitivity—Irinotecan—stomach cancer	0.00336	0.00658	CcSEcCtD
Mepenzolate—Drowsiness—Epirubicin—stomach cancer	0.00334	0.00653	CcSEcCtD
Mepenzolate—Palpitations—Capecitabine—stomach cancer	0.00331	0.00647	CcSEcCtD
Mepenzolate—Asthenia—Irinotecan—stomach cancer	0.00328	0.00641	CcSEcCtD
Mepenzolate—Hypersensitivity—Fluorouracil—stomach cancer	0.00322	0.0063	CcSEcCtD
Mepenzolate—Dry mouth—Docetaxel—stomach cancer	0.00322	0.0063	CcSEcCtD
Mepenzolate—Confusional state—Docetaxel—stomach cancer	0.00318	0.00623	CcSEcCtD
Mepenzolate—Anaphylactic shock—Docetaxel—stomach cancer	0.00316	0.00617	CcSEcCtD
Mepenzolate—Dry mouth—Capecitabine—stomach cancer	0.00312	0.0061	CcSEcCtD
Mepenzolate—Drowsiness—Doxorubicin—stomach cancer	0.00309	0.00604	CcSEcCtD
Mepenzolate—Confusional state—Capecitabine—stomach cancer	0.00308	0.00603	CcSEcCtD
Mepenzolate—Tachycardia—Docetaxel—stomach cancer	0.00308	0.00603	CcSEcCtD
Mepenzolate—Dizziness—Irinotecan—stomach cancer	0.00302	0.00591	CcSEcCtD
Mepenzolate—Tachycardia—Capecitabine—stomach cancer	0.00298	0.00583	CcSEcCtD
Mepenzolate—Vomiting—Irinotecan—stomach cancer	0.0029	0.00568	CcSEcCtD
Mepenzolate—Dizziness—Fluorouracil—stomach cancer	0.00289	0.00566	CcSEcCtD
Mepenzolate—Headache—Irinotecan—stomach cancer	0.00286	0.0056	CcSEcCtD
Mepenzolate—Insomnia—Docetaxel—stomach cancer	0.00286	0.00558	CcSEcCtD
Mepenzolate—Somnolence—Docetaxel—stomach cancer	0.00281	0.00549	CcSEcCtD
Mepenzolate—Vomiting—Fluorouracil—stomach cancer	0.00278	0.00544	CcSEcCtD
Mepenzolate—Insomnia—Capecitabine—stomach cancer	0.00276	0.00541	CcSEcCtD
Mepenzolate—Headache—Fluorouracil—stomach cancer	0.00274	0.00536	CcSEcCtD
Mepenzolate—Nausea—Irinotecan—stomach cancer	0.00271	0.00531	CcSEcCtD
Mepenzolate—Constipation—Docetaxel—stomach cancer	0.0027	0.00528	CcSEcCtD
Mepenzolate—Vision blurred—Methotrexate—stomach cancer	0.00263	0.00514	CcSEcCtD
Mepenzolate—Constipation—Capecitabine—stomach cancer	0.00261	0.00511	CcSEcCtD
Mepenzolate—Feeling abnormal—Docetaxel—stomach cancer	0.0026	0.00509	CcSEcCtD
Mepenzolate—Nausea—Fluorouracil—stomach cancer	0.0026	0.00508	CcSEcCtD
Mepenzolate—Tension—Epirubicin—stomach cancer	0.00256	0.00501	CcSEcCtD
Mepenzolate—Nervousness—Epirubicin—stomach cancer	0.00253	0.00496	CcSEcCtD
Mepenzolate—Feeling abnormal—Capecitabine—stomach cancer	0.00252	0.00493	CcSEcCtD
Mepenzolate—Vision blurred—Epirubicin—stomach cancer	0.00246	0.00481	CcSEcCtD
Mepenzolate—Urticaria—Capecitabine—stomach cancer	0.00243	0.00475	CcSEcCtD
Mepenzolate—Tension—Doxorubicin—stomach cancer	0.00237	0.00463	CcSEcCtD
Mepenzolate—Nervousness—Doxorubicin—stomach cancer	0.00234	0.00459	CcSEcCtD
Mepenzolate—Hypersensitivity—Docetaxel—stomach cancer	0.00233	0.00455	CcSEcCtD
Mepenzolate—Palpitations—Epirubicin—stomach cancer	0.00231	0.00451	CcSEcCtD
Mepenzolate—Confusional state—Methotrexate—stomach cancer	0.00229	0.00449	CcSEcCtD
Mepenzolate—Anaphylactic shock—Methotrexate—stomach cancer	0.00228	0.00445	CcSEcCtD
Mepenzolate—Vision blurred—Doxorubicin—stomach cancer	0.00228	0.00445	CcSEcCtD
Mepenzolate—Asthenia—Docetaxel—stomach cancer	0.00226	0.00443	CcSEcCtD
Mepenzolate—Hypersensitivity—Capecitabine—stomach cancer	0.00225	0.0044	CcSEcCtD
Mepenzolate—Asthenia—Capecitabine—stomach cancer	0.00219	0.00429	CcSEcCtD
Mepenzolate—Dry mouth—Epirubicin—stomach cancer	0.00217	0.00425	CcSEcCtD
Mepenzolate—Confusional state—Epirubicin—stomach cancer	0.00215	0.0042	CcSEcCtD
Mepenzolate—Palpitations—Doxorubicin—stomach cancer	0.00213	0.00417	CcSEcCtD
Mepenzolate—Anaphylactic shock—Epirubicin—stomach cancer	0.00213	0.00416	CcSEcCtD
Mepenzolate—Dizziness—Docetaxel—stomach cancer	0.00209	0.00408	CcSEcCtD
Mepenzolate—Tachycardia—Epirubicin—stomach cancer	0.00208	0.00406	CcSEcCtD
Mepenzolate—Insomnia—Methotrexate—stomach cancer	0.00206	0.00403	CcSEcCtD
Mepenzolate—Somnolence—Methotrexate—stomach cancer	0.00202	0.00396	CcSEcCtD
Mepenzolate—Dizziness—Capecitabine—stomach cancer	0.00202	0.00395	CcSEcCtD
Mepenzolate—Dry mouth—Doxorubicin—stomach cancer	0.00201	0.00393	CcSEcCtD
Mepenzolate—Vomiting—Docetaxel—stomach cancer	0.00201	0.00393	CcSEcCtD
Mepenzolate—Confusional state—Doxorubicin—stomach cancer	0.00199	0.00389	CcSEcCtD
Mepenzolate—Headache—Docetaxel—stomach cancer	0.00198	0.00387	CcSEcCtD
Mepenzolate—Anaphylactic shock—Doxorubicin—stomach cancer	0.00197	0.00385	CcSEcCtD
Mepenzolate—Vomiting—Capecitabine—stomach cancer	0.00194	0.0038	CcSEcCtD
Mepenzolate—Insomnia—Epirubicin—stomach cancer	0.00193	0.00377	CcSEcCtD
Mepenzolate—Tachycardia—Doxorubicin—stomach cancer	0.00192	0.00376	CcSEcCtD
Mepenzolate—Headache—Capecitabine—stomach cancer	0.00191	0.00375	CcSEcCtD
Mepenzolate—Somnolence—Epirubicin—stomach cancer	0.00189	0.0037	CcSEcCtD
Mepenzolate—Nausea—Docetaxel—stomach cancer	0.00188	0.00367	CcSEcCtD
Mepenzolate—Feeling abnormal—Methotrexate—stomach cancer	0.00187	0.00367	CcSEcCtD
Mepenzolate—Constipation—Epirubicin—stomach cancer	0.00182	0.00356	CcSEcCtD
Mepenzolate—Nausea—Capecitabine—stomach cancer	0.00182	0.00355	CcSEcCtD
Mepenzolate—Urticaria—Methotrexate—stomach cancer	0.00181	0.00354	CcSEcCtD
Mepenzolate—Insomnia—Doxorubicin—stomach cancer	0.00178	0.00349	CcSEcCtD
Mepenzolate—Feeling abnormal—Epirubicin—stomach cancer	0.00175	0.00343	CcSEcCtD
Mepenzolate—Somnolence—Doxorubicin—stomach cancer	0.00175	0.00343	CcSEcCtD
Mepenzolate—Urticaria—Epirubicin—stomach cancer	0.00169	0.00331	CcSEcCtD
Mepenzolate—Constipation—Doxorubicin—stomach cancer	0.00168	0.0033	CcSEcCtD
Mepenzolate—Hypersensitivity—Methotrexate—stomach cancer	0.00168	0.00328	CcSEcCtD
Mepenzolate—Asthenia—Methotrexate—stomach cancer	0.00163	0.00319	CcSEcCtD
Mepenzolate—Feeling abnormal—Doxorubicin—stomach cancer	0.00162	0.00318	CcSEcCtD
Mepenzolate—Hypersensitivity—Epirubicin—stomach cancer	0.00157	0.00307	CcSEcCtD
Mepenzolate—Urticaria—Doxorubicin—stomach cancer	0.00157	0.00306	CcSEcCtD
Mepenzolate—Asthenia—Epirubicin—stomach cancer	0.00153	0.00299	CcSEcCtD
Mepenzolate—Dizziness—Methotrexate—stomach cancer	0.0015	0.00294	CcSEcCtD
Mepenzolate—Hypersensitivity—Doxorubicin—stomach cancer	0.00145	0.00284	CcSEcCtD
Mepenzolate—Vomiting—Methotrexate—stomach cancer	0.00145	0.00283	CcSEcCtD
Mepenzolate—Headache—Methotrexate—stomach cancer	0.00143	0.00279	CcSEcCtD
Mepenzolate—Asthenia—Doxorubicin—stomach cancer	0.00141	0.00276	CcSEcCtD
Mepenzolate—Dizziness—Epirubicin—stomach cancer	0.00141	0.00275	CcSEcCtD
Mepenzolate—Vomiting—Epirubicin—stomach cancer	0.00135	0.00265	CcSEcCtD
Mepenzolate—Nausea—Methotrexate—stomach cancer	0.00135	0.00264	CcSEcCtD
Mepenzolate—Headache—Epirubicin—stomach cancer	0.00133	0.00261	CcSEcCtD
Mepenzolate—Dizziness—Doxorubicin—stomach cancer	0.0013	0.00255	CcSEcCtD
Mepenzolate—Nausea—Epirubicin—stomach cancer	0.00126	0.00247	CcSEcCtD
Mepenzolate—Vomiting—Doxorubicin—stomach cancer	0.00125	0.00245	CcSEcCtD
Mepenzolate—Headache—Doxorubicin—stomach cancer	0.00123	0.00241	CcSEcCtD
Mepenzolate—Nausea—Doxorubicin—stomach cancer	0.00117	0.00229	CcSEcCtD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000356	0.000728	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000356	0.000728	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ALDOB—stomach cancer	0.000353	0.000723	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—IL6—stomach cancer	0.00035	0.000716	CbGpPWpGaD
Mepenzolate—CHRM1—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000346	0.000709	CbGpPWpGaD
Mepenzolate—CHRM3—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000345	0.000706	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000337	0.00069	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000336	0.000688	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ALOX5—stomach cancer	0.000328	0.000672	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FST—stomach cancer	0.000324	0.000663	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—DPYD—stomach cancer	0.000323	0.000661	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FST—stomach cancer	0.000323	0.000661	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—ADRB2—stomach cancer	0.000322	0.000659	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—ADRB2—stomach cancer	0.000321	0.000657	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FST—stomach cancer	0.00032	0.000654	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—ADRB2—stomach cancer	0.000318	0.000651	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—HBEGF—stomach cancer	0.000317	0.000649	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—TP53—stomach cancer	0.000316	0.000647	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—HBEGF—stomach cancer	0.000316	0.000647	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—HBEGF—stomach cancer	0.000313	0.00064	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GAST—stomach cancer	0.000313	0.00064	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RGS2—stomach cancer	0.000313	0.00064	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GAST—stomach cancer	0.000312	0.000638	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RGS2—stomach cancer	0.000312	0.000638	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.00031	0.000634	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000309	0.000632	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RGS2—stomach cancer	0.000309	0.000631	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GAST—stomach cancer	0.000309	0.000631	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FGG—stomach cancer	0.000296	0.000606	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FGG—stomach cancer	0.000295	0.000604	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—ADRB2—stomach cancer	0.000293	0.000599	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FGG—stomach cancer	0.000293	0.000599	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—ADRB2—stomach cancer	0.000292	0.000597	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—IL6—stomach cancer	0.000289	0.000592	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—ADRB2—stomach cancer	0.000289	0.000591	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PPP2R1A—stomach cancer	0.000287	0.000587	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000287	0.000586	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PPP2R1A—stomach cancer	0.000286	0.000585	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GSTT1—stomach cancer	0.000286	0.000585	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000286	0.000585	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKAA1—stomach cancer	0.000285	0.000584	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKAA1—stomach cancer	0.000284	0.000582	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PPP2R1A—stomach cancer	0.000283	0.000579	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CYP2A6—stomach cancer	0.000282	0.000578	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKAA1—stomach cancer	0.000282	0.000576	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RBP4—stomach cancer	0.000276	0.000564	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—CXCL8—stomach cancer	0.000275	0.000563	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AKR1C3—stomach cancer	0.000275	0.000562	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RBP4—stomach cancer	0.000275	0.000562	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—CXCL8—stomach cancer	0.000274	0.000562	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000274	0.000561	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000273	0.000559	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RBP4—stomach cancer	0.000272	0.000556	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—CXCL8—stomach cancer	0.000272	0.000556	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ENO1—stomach cancer	0.000268	0.000548	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CD44—stomach cancer	0.000237	0.000486	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGTR2—stomach cancer	0.000237	0.000485	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HSPB1—stomach cancer	0.000237	0.000485	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HSPB1—stomach cancer	0.000236	0.000483	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGTR2—stomach cancer	0.000236	0.000483	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—F2R—stomach cancer	0.000234	0.000479	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—BMP2—stomach cancer	0.000234	0.000479	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HSPB1—stomach cancer	0.000234	0.000479	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGTR2—stomach cancer	0.000234	0.000479	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—BMP2—stomach cancer	0.000234	0.000478	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—F2R—stomach cancer	0.000234	0.000478	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—BMP2—stomach cancer	0.000231	0.000473	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—F2R—stomach cancer	0.000231	0.000473	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AKR1C3—stomach cancer	0.00023	0.000472	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AKR1C3—stomach cancer	0.00023	0.00047	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR1A—stomach cancer	0.000228	0.000467	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AKR1C3—stomach cancer	0.000228	0.000466	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR1A—stomach cancer	0.000227	0.000465	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR1A—stomach cancer	0.000225	0.000461	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PRKCB—stomach cancer	0.000221	0.000452	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ANXA1—stomach cancer	0.00022	0.000451	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PRKCB—stomach cancer	0.00022	0.00045	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ANXA1—stomach cancer	0.00022	0.000449	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PRKCB—stomach cancer	0.000218	0.000446	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ANXA1—stomach cancer	0.000217	0.000445	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADRB1—stomach cancer	0.000213	0.000436	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADRB1—stomach cancer	0.000213	0.000435	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADRB1—stomach cancer	0.000211	0.000431	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RPS6—stomach cancer	0.000204	0.000417	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RPS6—stomach cancer	0.000203	0.000416	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPP2R1A—stomach cancer	0.000202	0.000413	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RPS6—stomach cancer	0.000201	0.000412	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PRKCB—stomach cancer	0.000201	0.00041	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PRKCB—stomach cancer	0.0002	0.000409	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6ST—stomach cancer	0.0002	0.000409	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6ST—stomach cancer	0.000199	0.000407	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GSTP1—stomach cancer	0.000198	0.000405	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	0.000198	0.000405	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	0.000197	0.000403	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—HMOX1—stomach cancer	0.000195	0.0004	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HBEGF—stomach cancer	0.000187	0.000383	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HBEGF—stomach cancer	0.000187	0.000382	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HBEGF—stomach cancer	0.000185	0.000378	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—TYMS—stomach cancer	0.000184	0.000377	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GSTM1—stomach cancer	0.000182	0.000372	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6R—stomach cancer	0.000178	0.000365	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6R—stomach cancer	0.000178	0.000363	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	0.000177	0.000363	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	0.000177	0.000362	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6R—stomach cancer	0.000176	0.00036	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	0.000175	0.000358	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADRB2—stomach cancer	0.000173	0.000354	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADRB2—stomach cancer	0.000172	0.000353	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ERCC2—stomach cancer	0.000171	0.00035	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADRB2—stomach cancer	0.000171	0.000349	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	0.000169	0.000347	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	0.000169	0.000345	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	0.000167	0.000342	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—RHOA—stomach cancer	0.000161	0.000329	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MTHFR—stomach cancer	0.000161	0.000329	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—RHOA—stomach cancer	0.00016	0.000328	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—RHOA—stomach cancer	0.000159	0.000325	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SMAD4—stomach cancer	0.000157	0.000322	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SMAD4—stomach cancer	0.000157	0.000321	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	0.000156	0.000318	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SMAD4—stomach cancer	0.000155	0.000318	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	0.000155	0.000317	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	0.000154	0.000314	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FYN—stomach cancer	0.000149	0.000306	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FYN—stomach cancer	0.000149	0.000305	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CAV1—stomach cancer	0.000148	0.000304	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOA1—stomach cancer	0.000148	0.000303	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FYN—stomach cancer	0.000147	0.000302	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	0.000141	0.000289	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	0.000141	0.000288	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FGFR2—stomach cancer	0.00014	0.000287	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FGFR2—stomach cancer	0.00014	0.000286	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	0.000139	0.000285	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FGFR2—stomach cancer	0.000138	0.000283	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PPARG—stomach cancer	0.00013	0.000267	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IRS2—stomach cancer	0.000128	0.000263	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IRS2—stomach cancer	0.000128	0.000262	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IRS2—stomach cancer	0.000127	0.000259	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CAV1—stomach cancer	0.000124	0.000255	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOA1—stomach cancer	0.000124	0.000254	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CAV1—stomach cancer	0.000124	0.000254	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOA1—stomach cancer	0.000124	0.000253	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CAV1—stomach cancer	0.000123	0.000251	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOA1—stomach cancer	0.000123	0.000251	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKCB—stomach cancer	0.000118	0.000242	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKCB—stomach cancer	0.000118	0.000242	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6ST—stomach cancer	0.000118	0.000241	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6ST—stomach cancer	0.000118	0.000241	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ALB—stomach cancer	0.000117	0.00024	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKCB—stomach cancer	0.000117	0.000239	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6ST—stomach cancer	0.000116	0.000238	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APC—stomach cancer	0.000113	0.000232	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APC—stomach cancer	0.000113	0.000231	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—NOS3—stomach cancer	0.000112	0.00023	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APC—stomach cancer	0.000112	0.000229	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	0.000109	0.000222	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	0.000108	0.000221	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	0.000107	0.000219	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6R—stomach cancer	0.000105	0.000215	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6R—stomach cancer	0.000105	0.000215	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6R—stomach cancer	0.000104	0.000213	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	0.000103	0.000211	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—EGFR—stomach cancer	0.000103	0.000211	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	0.000103	0.000211	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—EGFR—stomach cancer	0.000103	0.000211	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PTGS2—stomach cancer	0.000103	0.00021	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	0.000102	0.000209	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—EGFR—stomach cancer	0.000102	0.000209	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	9.87e-05	0.000202	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	9.86e-05	0.000202	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	9.84e-05	0.000201	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	9.83e-05	0.000201	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—KRAS—stomach cancer	9.76e-05	0.0002	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	9.74e-05	0.000199	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	9.73e-05	0.000199	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—KRAS—stomach cancer	9.73e-05	0.000199	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—KRAS—stomach cancer	9.63e-05	0.000197	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RHOA—stomach cancer	9.51e-05	0.000195	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RHOA—stomach cancer	9.48e-05	0.000194	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NOS3—stomach cancer	9.41e-05	0.000193	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RHOA—stomach cancer	9.39e-05	0.000192	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NOS3—stomach cancer	9.38e-05	0.000192	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NOS3—stomach cancer	9.29e-05	0.00019	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	8.96e-05	0.000183	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	8.94e-05	0.000183	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	8.85e-05	0.000181	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ERBB2—stomach cancer	8.8e-05	0.00018	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ERBB2—stomach cancer	8.77e-05	0.00018	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ERBB2—stomach cancer	8.69e-05	0.000178	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCL8—stomach cancer	8.35e-05	0.000171	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCL8—stomach cancer	8.32e-05	0.00017	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—HRAS—stomach cancer	8.29e-05	0.00017	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—HRAS—stomach cancer	8.27e-05	0.000169	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCL8—stomach cancer	8.24e-05	0.000169	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—HRAS—stomach cancer	8.19e-05	0.000168	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	8.15e-05	0.000167	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	8.13e-05	0.000166	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	8.05e-05	0.000165	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6—stomach cancer	7.94e-05	0.000162	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6—stomach cancer	7.91e-05	0.000162	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6—stomach cancer	7.84e-05	0.00016	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCND1—stomach cancer	7.78e-05	0.000159	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—JUN—stomach cancer	7.76e-05	0.000159	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCND1—stomach cancer	7.75e-05	0.000159	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—JUN—stomach cancer	7.74e-05	0.000158	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCND1—stomach cancer	7.68e-05	0.000157	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—JUN—stomach cancer	7.66e-05	0.000157	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MMP9—stomach cancer	7.55e-05	0.000154	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MMP9—stomach cancer	7.53e-05	0.000154	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	7.52e-05	0.000154	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	7.5e-05	0.000153	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MMP9—stomach cancer	7.45e-05	0.000153	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	7.43e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK8—stomach cancer	7.34e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK8—stomach cancer	7.32e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK8—stomach cancer	7.25e-05	0.000148	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—VEGFA—stomach cancer	6.78e-05	0.000139	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—VEGFA—stomach cancer	6.76e-05	0.000138	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—STAT3—stomach cancer	6.71e-05	0.000137	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—VEGFA—stomach cancer	6.69e-05	0.000137	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—STAT3—stomach cancer	6.69e-05	0.000137	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—STAT3—stomach cancer	6.63e-05	0.000136	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK3—stomach cancer	6.41e-05	0.000131	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK3—stomach cancer	6.39e-05	0.000131	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK3—stomach cancer	6.33e-05	0.00013	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PIK3CA—stomach cancer	6.31e-05	0.000129	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MYC—stomach cancer	6.24e-05	0.000128	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MYC—stomach cancer	6.22e-05	0.000127	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MYC—stomach cancer	6.16e-05	0.000126	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MAPK1—stomach cancer	6.1e-05	0.000125	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EGFR—stomach cancer	6.1e-05	0.000125	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MAPK1—stomach cancer	6.08e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EGFR—stomach cancer	6.08e-05	0.000124	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MAPK1—stomach cancer	6.02e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EGFR—stomach cancer	6.02e-05	0.000123	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KRAS—stomach cancer	5.76e-05	0.000118	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KRAS—stomach cancer	5.75e-05	0.000118	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KRAS—stomach cancer	5.69e-05	0.000116	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	5.3e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	5.28e-05	0.000108	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	5.23e-05	0.000107	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TP53—stomach cancer	5.12e-05	0.000105	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TP53—stomach cancer	5.11e-05	0.000104	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TP53—stomach cancer	5.06e-05	0.000103	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HRAS—stomach cancer	4.9e-05	0.0001	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HRAS—stomach cancer	4.88e-05	9.99e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HRAS—stomach cancer	4.84e-05	9.9e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6—stomach cancer	4.69e-05	9.59e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6—stomach cancer	4.67e-05	9.56e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6—stomach cancer	4.63e-05	9.47e-05	CbGpPWpGaD
